Three Weekly Irinotecan for Refractory/Relapsed Small Cell Lung Cancer

被引：0
|
作者：
Nutalapati, S. [1 ]
Yan, D. [1 ]
Morgan, R. [1 ]
Chauhan, A. [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
high-grade neuroendocrine carcinoma; Small cell lung cancer; Irinotecan;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P63.14
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [1] Every three weekly irinotecan for refractory/ relapsed small cell lung cancer.
    Nutalapati, Snigdha
    Yan, Donglin
    Morgan, Rachael
    Chauhan, Aman
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer
    Naka, N
    Kawahara, M
    Okishio, K
    Hosoe, S
    Ogawara, M
    Atagi, S
    Takemoto, Y
    Ueno, K
    Kawaguchi, T
    Tsuchiyama, T
    Furuse, K
    LUNG CANCER, 2002, 37 (03) : 319 - 323
  • [3] Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer
    Ando, M
    Kobayashi, K
    Yoshimura, A
    Kurimoto, F
    Seike, M
    Nara, M
    Moriyama, G
    Mizutani, H
    Hibino, S
    Gemma, A
    Okano, T
    Shibuya, M
    Kudoh, S
    LUNG CANCER, 2004, 44 (01) : 121 - 127
  • [4] Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer
    Yilmaz, Feride
    Yasar, Serkan
    Tatar, Omer Denizhan
    Yildirim, Hasan Cagri
    Guven, Deniz Can
    Akyildiz, Arif
    Chalabiyev, Elvin
    Aktas, Burak Yasin
    Arik, Zafer
    Erman, Mustafa
    BMC CANCER, 2024, 24 (01)
  • [5] Irinotecan in combination with platinum in refractory or relapsed small cell lung cancer.
    Yu, Shufei
    Wang, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Phase II study of weekly cisplatin, etoposide and irinotecan (PE/CPT) for refractory relapsed small cell lung cancer (SCLC).
    Kim, Y.
    Goto, K.
    Nishiwaki, Y.
    Kubota, K.
    Omatsu, H.
    Tamura, T.
    Ohe, Y.
    Kunitoh, H.
    Sekine, I.
    Yamamoto, N.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 386S - 386S
  • [7] Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer
    Masuda, N
    Matsui, K
    Negoro, S
    Takifuji, N
    Takeda, K
    Yana, T
    Kobayashi, M
    Hirashima, T
    Kusunoki, Y
    Ushijima, S
    Kawase, I
    Tada, T
    Sawaguchi, H
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3329 - 3334
  • [8] Irinotecan and carboplatin in relapsed small cell lung cancer
    Forrest, J.
    Randall, C.
    Lansdell, K.
    Earl, S.
    Cloos, B.
    Hadjiyiannakis, D.
    LUNG CANCER, 2008, 60 : S4 - S4
  • [9] Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer
    Yamamoto, N
    Tsurutani, J
    Yoshimura, N
    Asai, G
    Moriyama, A
    Nakagawa, K
    Kudoh, S
    Takada, M
    Minato, Y
    Fukuoka, M
    ANTICANCER RESEARCH, 2006, 26 (1B) : 777 - 781
  • [10] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
12345